Evidence that M1 muscarinic receptors enhance noradrenaline release in mouse atria by activating protein kinase C

British Journal of Pharmacology

Volumn 110, Issue 2, 1993, Pages 910-916

  Costa, Mary ^a   Barrington, Michelle ^a   Majewski, Henryk ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

calmodulin antagonists; M1 muscarinic receptors; McNeil A 343; Noradrenaline release; protein kinase C

Indexed keywords

8 BROMO CYCLIC AMP; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; CALMIDAZOLIUM; ISOBUTYLMETHYLXANTHINE; MUSCARINIC M1 RECEPTOR; N (3 PHENOXY 3 PHENYLALLYL)ACETOHYDROXAMIC ACID; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; N [3 (3 PHENOXYPHENYL)ALLYL]ACETOHYDROXAMIC ACID; NORADRENALIN; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; 8 BROMO CYCLIC ADENOSINE MONOPHOSPHATE; CALMODULIN; CYCLIC AMP; LIPOXYGENASE INHIBITOR; MUSCARINIC RECEPTOR; PHORBOL DIBUTYRATE; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENZYME ACTIVATION; HEART ATRIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; DRUG EFFECT; ELECTROSTIMULATION; ENZYMOLOGY; FEMALE; HEART MUSCLE; IN VITRO STUDY; MALE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

1-METHYL-3-ISOBUTYLXANTHINE; 8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMAL; CALMODULIN; CYCLIC AMP; ELECTRIC STIMULATION; ENZYME ACTIVATION; FEMALE; HEART ATRIUM; IN VITRO; LIPOXYGENASE INHIBITORS; MALE; MCN-A-343; MICE; MYOCARDIUM; NOREPINEPHRINE; PHORBOL 12,13-DIBUTYRATE; PROTEIN KINASE C; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T;

EID: 0027337794     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1993.tb13899.x     Document Type: Article

References (54)

1. 3H‐noradrenaline by guinea‐pig atria
2. 3H]‐noradrenaline from rabbit isolated ear arteries and guinea‐pig atria
3. Further evidence of a presynaptic excitatory M1 muscarinic receptor at postganglionic cardiac adrenergic nerves
4. 3H)‐ACH release by muscarinic receptors in the rat, differences between occipital cortical, striatal and atrial slices
5. Inositol trisphosphate and diacylglycerol: two interacting second messengers
6. Inositol trisphosphate, a novel second messenger in cellular signal transduction
7. Cyclic nucleotide metabolism in the sympathetic ganglion
8. Facilitation of noradrenaline release from sympathetic nerves through activation of ACTH receptors, β‐adrenoceptors and angiotensin II receptors
9. Inhibitory prejunctional muscarinic receptors at sympathetic nerves do not function through a cyclic AMP dependent pathway
10. Evidence for facilitatory and inhibitory muscarinic receptors on postganglionic sympathetic nerves in mouse isolated atria
11. The calmodulin hypothesis of neurotransmission
12. Calcium and calmodulin control of neurotransmitter synthesis and release
13. Muscarinic agonists evoke neurotransmitter release: possible roles for phosphatidyl inositol bisphosphate breakdown products in neuromodulation
14. Muscarinic receptor subtypes: a critique of the current classification and a proposal for a working nomenclature
15. Receptor activation and inositol lipid hydrolysis and neural tissues
16. Long term treatment with phorbol esters and the modulation of noradrenaline release
17. Atropine‐resistant effects of the muscarinic agonists McN‐A‐343 and AHR 602 on cardiac performance and the release of noradrenaline from sympathetic nerves of the perfused rabbit heart
18. Role of cAMP for regulation of impulse‐evoked noradrenaline release from the rabbit pulmonary artery and its possible relationship to presynaptic ACTH receptors
19. Neuronal phosphoproteins. Mediators of signal transduction
20. A presynaptic excitatory M1 muscarine receptor at postganglionic cardiac noradrenergic nerve fibres that is activated by endogenous acetylcholine
21. Muscarinic cholinergic receptors in rat corpus striatum and regulation of guanosine cyclic 3′,5′ monophosphate
22. Basic mechanisms of prostaglandin action on autonomic neurotransmission
23. Activity‐structure relationship of calmodulin antagonists. Naphthalenesulfonamide derivatives
24. Enhancement of spontaneous acetylcholine release from motor nerve terminal by calmodulin inhibitors
25. Involvement of cyclic nucleotides in prejunctional modulation of noradrenaline release in mouse atria
26. Release of prostaglandin from the rabbit isolated heart followng vagal nerve stimulation or acetylcholine infusion
27. K‐252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide‐dependent protein kinases
28. Regional sensitivity of cyclic AMP and cyclic GMP in rat brain to central cholinergic stimulation
29. Selective binding of antipsychotics and other psychoactive agents to the calcium‐dependent activator of cyclic nucleotide phosphodiesterase
30. Intraterminal injection of synapsin I or calcium/calmodulin‐dependent protein kianse II alters neurotransmitter release at the squid giant synapse
31. Second messengers are involved in facilitatory but not inhibitory receptor actions at sympathetic nerve endings
32. Intra‐neuronal mechanisms involved in the modulation of noradrenaline release through prejunctional receptors
33. Prostaglandins and the release of the adrenergic transmitter
34. Down regulation of protein kinase C in neuronal cells: effects on neurotransmitter release
35. Muscarinic receptor differentiation
36. Peripheral muscarinic control of norepinephrine release in the cardiovascular system
37. A presynaptic excitatory M1 muscarinic receptor at postganglionic cardiac adrenergic fibers that is activated by endogenous acetylcholine
38. Evidence that angiotensin II enhances noradrenaline release from sympathetic nerves in mouse atria by activating protein kinase C
39. Effect of phorbol esters and polymyxin B on modulation of noradrenaline release in mouse atria
40. K‐252a, a novel microbial product, inhibits smooth muscle myosin light chain kinase
41. Molecular properties of the muscarinic acetylcholine receptor
42. Modulation by the muscarinic agonist McN‐A‐343 of noradrenaline release from vascular sympathetic neurones
43. Protein kinase C
44. Turnover of inositol phospholipids and signal transduction
45. Studies and perspectives of protein kinase C
46. Stimulation of adenylate cyclase activity as a novel signal transduction mechanism for central muscarinic receptors
47. Calmodulin, synchronous and asynchronous release of neurotransmitter
48. W‐7 at calmodulin‐antagonistic concentrations facilitates noradrenaline release from rat brain cortex slices
49. Staurosporine, K‐252 and UCN‐01: potent but nonspecific inhibitors of protein kinases
50. Selective inhibition of arachidonate 5‐lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo
51. R 24 571: a potent inhibitor of calmodulin‐activated enzymes
52. Heterogeneity of presynaptic muscarinic receptors involved in modulation of transmitter release
53. In vivo striatal dopamine release by M1 muscarinic receptors is induced by activation of protein kinase C
54. Down‐regulation of protein kinase C is due to an increased rate of degradation